These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21856359)

  • 1. Rotavirus shedding in premature infants following first immunization.
    Smith CK; McNeal MM; Meyer NR; Haase S; Dekker CL
    Vaccine; 2011 Oct; 29(45):8141-6. PubMed ID: 21856359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine.
    Hsieh YC; Wu FT; Hsiung CA; Wu HS; Chang KY; Huang YC
    Vaccine; 2014 Feb; 32(10):1199-204. PubMed ID: 24076325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jan; 119(1):171-82. PubMed ID: 17200286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breastfeeding linked to the reduction of both rotavirus shedding and IgA levels after Rotarix® immunization in Mexican infants.
    Bautista-Marquez A; Velasquez DE; Esparza-Aguilar M; Luna-Cruz M; Ruiz-Moran T; Sugata K; Jiang B; Parashar U; Patel M; Richardson V
    Vaccine; 2016 Oct; 34(44):5284-5289. PubMed ID: 27663670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D; Boniface K; Bogdanovic-Sakran N; Kirkwood CD; Bines JE
    Hum Vaccin Immunother; 2017 Aug; 13(8):1908-1915. PubMed ID: 28481726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus Vaccination Can Be Performed Without Viral Dissemination in the Neonatal Intensive Care Unit.
    Hiramatsu H; Suzuki R; Nagatani A; Boda H; Miyata M; Hattori F; Miura H; Sugata K; Yamada S; Komoto S; Taniguchi K; Ihira M; Nishimura N; Ozaki T; Yoshikawa T
    J Infect Dis; 2018 Jan; 217(4):589-596. PubMed ID: 29165657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring Shedding of Five Genotypes of RotaTeq Vaccine Viruses by Genotype-Specific Real-Time Reverse Transcription-PCR Assays.
    Higashimoto Y; Ihira M; Miyazaki Y; Kuboshiki A; Yoshinaga S; Hiramatsu H; Suzuki R; Miyata M; Miura H; Komoto S; Yukitake J; Taniguchi K; Kawamura Y; Yoshikawa T
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.
    Goveia MG; Rodriguez ZM; Dallas MJ; Itzler RF; Boslego JW; Heaton PM; DiNubile MJ;
    Pediatr Infect Dis J; 2007 Dec; 26(12):1099-104. PubMed ID: 18043445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine.
    Yen C; Jakob K; Esona MD; Peckham X; Rausch J; Hull JJ; Whittier S; Gentsch JR; LaRussa P
    Vaccine; 2011 May; 29(24):4151-5. PubMed ID: 21477676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shedding of oral pentavalent bovine-human reassortant rotavirus vaccine indicates high uptake rate of vaccine and prominence of G-type G1.
    Markkula J; Hemming-Harlo M; Vesikari T
    Vaccine; 2020 Feb; 38(6):1378-1383. PubMed ID: 31862199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Horizontal transmission of a human rotavirus vaccine strain--a randomized, placebo-controlled study in twins.
    Rivera L; Peña LM; Stainier I; Gillard P; Cheuvart B; Smolenov I; Ortega-Barria E; Han HH
    Vaccine; 2011 Nov; 29(51):9508-13. PubMed ID: 22008819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of PCV-2 DNA in stool samples from infants vaccinated with RotaTeq®.
    Esona MD; Mijatovic-Rustempasic S; Yen C; Parashar UD; Gentsch JR; Bowen MD; LaRussa P
    Hum Vaccin Immunother; 2014; 10(1):25-32. PubMed ID: 24104203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.
    Dennehy PH; Goveia MG; Dallas MJ; Heaton PM
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S36-42. PubMed ID: 18162245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa.
    Steele AD; Madhi SA; Louw CE; Bos P; Tumbo JM; Werner CM; Bicer C; De Vos B; Delem A; Han HH
    Pediatr Infect Dis J; 2011 Feb; 30(2):125-30. PubMed ID: 20842070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-derived human-bovine double reassortant rotavirus in infants with acute gastroenteritis.
    Hemming M; Vesikari T
    Pediatr Infect Dis J; 2012 Sep; 31(9):992-4. PubMed ID: 22581224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination.
    Donato CM; Ch'ng LS; Boniface KF; Crawford NW; Buttery JP; Lyon M; Bishop RF; Kirkwood CD
    J Infect Dis; 2012 Aug; 206(3):377-83. PubMed ID: 22615314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix(®) and RotaTeq(®) vaccine strains in stool samples.
    Gautam R; Esona MD; Mijatovic-Rustempasic S; Ian Tam K; Gentsch JR; Bowen MD
    Hum Vaccin Immunother; 2014; 10(3):767-77. PubMed ID: 24342877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation.
    Clark HF; Burke CJ; Volkin DB; Offit P; Ward RL; Bresee JS; Dennehy P; Gooch WM; Malacaman E; Matson D; Walter E; Watson B; Krah DL; Dallas MJ; Schödel F; Kaplan kM; Heaton P
    Pediatr Infect Dis J; 2003 Oct; 22(10):914-20. PubMed ID: 14551493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.